Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial

Autor: Jimenez, Camilo *, Habra, Mouhammed Amir, Campbell, Matthew T, Tamsen, Gina, Cruz-Goldberg, Damaris, Long, James, Bassett, Roland, Dantzer, Robert, Balderrama-Brondani, Vania, Varghese, Jeena, Lu, Yang
Zdroj: In The Lancet Oncology May 2024 25(5):658-667
Databáze: ScienceDirect